BIOLOGICAL PROPERTIES OF HIV ISOLATES IN PRIMARY HIV-INFECTION - CONSEQUENCES FOR THE SUBSEQUENT COURSE OF INFECTION

被引:92
|
作者
NIELSEN, C
PEDERSEN, C
LUNDGREN, JD
GERSTOFT, J
机构
[1] HVIDOVRE UNIV HOSP,DEPT INFECT DIS,DK-2650 HVIDOVRE,DENMARK
[2] RIGSHOSP,DEPT INFECT DIS,DK-2100 COPENHAGEN,DENMARK
关键词
HIV; HIV PHENOTYPE; PRIMARY HIV INFECTION; SEROCONVERSION; PROGRESSION;
D O I
10.1097/00002030-199308000-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To characterize the biological properties of HIV isolates obtained at the time of primary infection, and relate this to the subsequent course of the infection. Methods: Syncytium-inducing (SI) capacity, tropism for cell lines (MT4 and H9) and replication rate were determined in 49 HIV isolates obtained from 17 HIV seroconverters. Thirteen of the 17 patients had a symptomatic primary HIV infection. Correlation between biological phenotype and clinical progression was analysed. Results: SI isolates were recovered in six patients from the first sample taken during primary infection, non-SI (NSI) isolates only were identified in 10 of the patients and isolation culture was negative in one patient. For all patients from whom SI virus was initially isolated, this phenotype persisted during the follow-up period (range, 17-219 weeks). The duration of fever during primary infection was longer for patients with SI isolates than for patients with NSI isolates (P = 0.05). Both types of isolates were associated with a significant fall in CD4 lymphocytes during follow-up (P < 0.05). Patients with SI isolates developed HIV-related immune deficiency more rapidly than patients with NSI isolates (P < 0.05). Conclusions: The biological phenotype of HIV strains isolated during the time of seroconversion may be an important determinant of the subsequent course of the infection.
引用
收藏
页码:1035 / 1040
页数:6
相关论文
共 50 条
  • [1] CLINICAL COURSE OF PRIMARY HIV INFECTION - CONSEQUENCES FOR SUBSEQUENT COURSE OF INFECTION
    PEDERSEN, C
    LINDHARDT, BO
    JENSEN, BL
    LAURITZEN, E
    GERSTOFT, J
    DICKMEISS, E
    GAUB, J
    SCHEIBEL, E
    KARLSMARK, T
    BRITISH MEDICAL JOURNAL, 1989, 299 (6692): : 154 - 157
  • [2] ENDOCRINE CONSEQUENCES OF HIV-INFECTION
    SCHLIENGER, JL
    LANG, JM
    SEMAINE DES HOPITAUX, 1990, 66 (05): : 245 - 250
  • [3] MALIGNANCIES IN THE COURSE OF HIV-INFECTION
    KERN, P
    MEIGEL, W
    RACZ, P
    TENNERRACZ, K
    SEIDEL, H
    DIETRICH, M
    BLUT, 1987, 55 (04): : 302 - 302
  • [4] CHOLESTEROL IN THE COURSE OF HIV-INFECTION
    CHLEBOWSKI, RT
    TAI, V
    GROSVENOR, M
    LILLINGTON, L
    KRUGER, S
    BEALL, G
    CLINICAL RESEARCH, 1992, 40 (02): : A205 - A205
  • [5] Lipodystrophia in the course of HIV-infection
    Mercié, P
    Faure, I
    Viallard, JF
    Leng, B
    Pellegrin, JL
    REVUE DE MEDECINE INTERNE, 2000, 21 (07): : 635 - 636
  • [6] THE COURSE OF HIV-INFECTION IN ADOLESCENTS
    AHLSTROM, PA
    RICHMOND, D
    TOWNSEND, C
    DANGELO, LJ
    JOURNAL OF ADOLESCENT HEALTH, 1992, 13 (01) : 49 - 49
  • [7] PRIMARY CARE FOR HIV-INFECTION
    LYNN, LA
    HOSPITAL PRACTICE, 1992, 27 (2A): : 48 - &
  • [8] ACUTE (PRIMARY) HIV-INFECTION
    PICARD, C
    OBERLIN, P
    LAZARETH, I
    CRICKX, B
    BELAICH, S
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1990, 117 (11): : 861 - 864
  • [9] PRIMARY PROPHYLAXIS OF HIV-INFECTION
    BAUER, G
    HEUSSER, R
    BEUTTER, HJ
    STEFFEN, R
    GUTZWILLER, F
    THERAPEUTISCHE UMSCHAU, 1991, 48 (04) : 251 - 257
  • [10] CONSEQUENCES OF HIV-INFECTION - AUTOIMMUNITY AND CANCER
    LEVY, JA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 474 - 475